Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRx-150 plus DMARD therapy vs placebo plus DMARD therapy in rheumatoid arthritis
2004-001490-26Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in rheumatoid arthritis (RA) comparing CRx-150 plus DMARD therapy with Placebo plus DMARD therapy (2 arms). Primary endpoint: Primary: Reduction in serum C-reactive protein (CRP). Started Jun 2005; status: completed.
02
Drugs
pseudoephedrine + naproxen
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-001490-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001490-26.